Delivery Order SPE2DB20D1109-SPE2DB22FN02B
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,984.27, is for the delivery of the medication Corlanor 5 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.72 firm fixed-price delivery order is for the supply of Corlanor 5 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $84,183.40, is for the delivery of the medication Corlanor 5 mg tablets. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,059.99 firm fixed-price delivery order is for the supply of Corlanor 5 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 60 tablets of the pharmaceutical product CORLANOR 7.5 MG. The $2,062.78 fixed-price delivery order has an ultimate completion date of December 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $1,341.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025, and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,327.08 firm fixed-price delivery order is for the medication Corlanor 5 mg tablet, with an ultimate completion date of April 11, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,961.54 firm fixed-price delivery order is for the supply of 4565006668 - CORLANOR 5 MG TABLET 60S, a pharmaceutical product. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,323.16, is for the delivery of the medication Corlanor 5 mg tablets. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,093.94 firm fixed-price delivery order is for the supply of Corlanor 5 mg tablets, a cardiovascular medication, with a completion date of September 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FN02BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Corlanor 7.5 mg tablets. The $6,804.27 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is a subsidiary of the parent company Cencora, Inc., which also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 11/4/21 |